These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25990232)

  • 101. Differences in the epidemiology between paediatric and adult invasive Streptococcus pyogenes infections.
    Zachariadou L; Stathi A; Tassios PT; Pangalis A; Legakis NJ; Papaparaskevas J;
    Epidemiol Infect; 2014 Mar; 142(3):512-9. PubMed ID: 23746128
    [TBL] [Abstract][Full Text] [Related]  

  • 102. A multi-center clinical investigation on invasive Streptococcus pyogenes infection in China, 2010-2017.
    Hua CZ; Yu H; Xu HM; Yang LH; Lin AW; Lyu Q; Lu HP; Xu ZW; Gao W; Chen XJ; Wang CQ; Jing CM
    BMC Pediatr; 2019 Jun; 19(1):181. PubMed ID: 31167650
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Epidemiological analysis of group A streptococci recovered from patients in China.
    Jing HB; Ning BA; Hao HJ; Zheng YL; Chang D; Jiang W; Jiang YQ
    J Med Microbiol; 2006 Aug; 55(Pt 8):1101-1107. PubMed ID: 16849731
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens.
    Kanellopoulou M; Makri A; Damaskopoulou H; Malamou-Lada H
    Clin Microbiol Infect; 2000 Dec; 6(12):653-6. PubMed ID: 11284924
    [TBL] [Abstract][Full Text] [Related]  

  • 105. M1
    Mavroidi A; Katsiaflaka A; Petinaki E; Froukala E; Papadopoulos D; Vrioni G; Tsakris A
    J Glob Antimicrob Resist; 2024 Jun; 37():185-189. PubMed ID: 38552876
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003.
    Sierra JM; Sánchez F; Castro P; Salvadó M; de la Red G; Libois A; Almela M; March F; Español M; Sambeat MA; Romeu J; Brugal MT; de Olalla PG; Gatell JM; Vila J; García F; Colomés JLL; Caylà JA; Coll P
    Medicine (Baltimore); 2006 May; 85(3):139-146. PubMed ID: 16721256
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Erythromycin-resistant group A streptococcal isolates recovered in Sofia, Bulgaria, from 1995 to 2001.
    Detcheva A; Facklam RR; Beall B
    J Clin Microbiol; 2002 Oct; 40(10):3831-4. PubMed ID: 12354892
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Detection of Streptococcus pyogenes by use of Illumigene group A Streptococcus assay.
    Henson AM; Carter D; Todd K; Shulman ST; Zheng X
    J Clin Microbiol; 2013 Dec; 51(12):4207-9. PubMed ID: 24048538
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Genetic evolution of invasive emm28 Streptococcus pyogenes strains and significant association with puerperal infections in young women in Finland.
    Gröndahl-Yli-Hannuksela K; Beres SB; Hyyryläinen HL; Kallonen T; Musser JM; Vuopio J
    Clin Microbiol Infect; 2021 Mar; 27(3):420-427. PubMed ID: 32289480
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Genetic diversity of cell-invasive erythromycin-resistant and -susceptible group A streptococci determined by analysis of the RD2 region of the prtF1 gene.
    Spinaci C; Magi G; Zampaloni C; Vitali LA; Paoletti C; Catania MR; Prenna M; Ferrante L; Ripa S; Varaldo PE; Facinelli B
    J Clin Microbiol; 2004 Feb; 42(2):639-44. PubMed ID: 14766830
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy.
    Dicuonzo G; Fiscarelli E; Gherardi G; Lorino G; Battistoni F; Landi S; De Cesaris M; Petitti T; Beall B
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3987-90. PubMed ID: 12435707
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Clindamycin-induced CovS-mediated regulation of the production of virulent exoproteins streptolysin O, NAD glycohydrolase, and streptokinase in Streptococcus pyogenes.
    Minami M; Kamimura T; Isaka M; Tatsuno I; Ohta M; Hasegawa T
    Antimicrob Agents Chemother; 2010 Jan; 54(1):98-102. PubMed ID: 19805566
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Genomic Characterization of Group A Streptococci Causing Pharyngitis and Invasive Disease in Colorado, USA, June 2016- April 2017.
    Li Y; Dominguez S; Nanduri SA; Rivers J; Mathis S; Li Z; McGee L; Chochua S; Metcalf BJ; Van Beneden CA; Beall B; Miller L
    J Infect Dis; 2022 May; 225(10):1841-1851. PubMed ID: 34788828
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Efficacy and side-effect profile of tedizolid in the treatment of streptococcal toxic shock syndrome due to clindamycin-resistant Streptococcus pyogenes: A case report.
    Yokota K; Kawakami K
    J Infect Chemother; 2024 Aug; 30(8):785-788. PubMed ID: 38185364
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Non-Necrotizing Soft Tissue Infection and Streptococcal Toxic Shock Syndrome Caused by a Novel Streptococcus pyogenes Subtype (emm76.10).
    Hashiyama T; Mori N; Fukushima Y; Takahashi T
    Jpn J Infect Dis; 2020 Sep; 73(5):373-376. PubMed ID: 32350222
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Interspecies recombination occurs frequently in quinolone resistance-determining regions of clinical isolates of Streptococcus pyogenes.
    Duesberg CB; Malhotra-Kumar S; Goossens H; McGee L; Klugman KP; Welte T; Pletz MW
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4191-3. PubMed ID: 18765693
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate.
    Cortés-Penfield N; Ryder JH
    Clin Infect Dis; 2023 Jan; 76(2):346-350. PubMed ID: 36056891
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Risk Factors and Predictors of Mortality in Streptococcal Necrotizing Soft-tissue Infections: A Multicenter Prospective Study.
    Bruun T; Rath E; Madsen MB; Oppegaard O; Nekludov M; Arnell P; Karlsson Y; Babbar A; Bergey F; Itzek A; Hyldegaard O; Norrby-Teglund A; Skrede S;
    Clin Infect Dis; 2021 Jan; 72(2):293-300. PubMed ID: 31923305
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Factors that cause trimethoprim resistance in Streptococcus pyogenes.
    Bergmann R; van der Linden M; Chhatwal GS; Nitsche-Schmitz DP
    Antimicrob Agents Chemother; 2014; 58(4):2281-8. PubMed ID: 24492367
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Antibiotic susceptibility of group A streptococci: a 6-year follow-up study.
    Betriu C; Sanchez A; Gomez M; Cruceyra A; Picazo JJ
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1717-9. PubMed ID: 8215292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.